Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. 1993

K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

The hepatobiliary transport of nonmetabolizable organic anions [cefodizime, dibromosulfophthalein, and indocyanine green (ICG)] was kinetically analyzed in Eisai hyperbilirubinemic rats (EHBR; Sprague-Dawley-derived mutant rats with conjugated hyperbilirubinemia). In EHBR, the biliary excretion of these anions was remarkably impaired, whereas the alteration in initial plasma disappearance was minimal. The kinetic analysis of the disposition of these ligands revealed 1) that the transport rate via bile canalicular membrane was severely impaired in EHBR for cefodizime and dibromosulfophthalein and 2) that the intracellular transport rate of ICG was decreased in EHBR, which contributed more than the decrease in the canalicular membrane transport to the net reduction of the excretion rate of ICG in EHBR. The latter finding was also supported by the in vitro results; the binding of ICG to ligandin(s) in EHBR was less extensive compared with that in normal rats, resulting in the higher distribution of ICG to organelle. Because the ligand molecules bound to organelle diffuse within the cells much more slowly than the molecules in the cytosol, the higher distribution of ICG to organelle in EHBR results in the reduction in the intracellular transport rate. These results indicate that the differential impairment mechanisms can be proposed for the excretion of organic anions: One is the impairment in the transport rate across the canalicular membrane, the other is the impairment in the intracellular transport rate.

UI MeSH Term Description Entries
D007208 Indocyanine Green A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output. Cardio-Green,Cardiogreen,Ujoveridin,Vofaverdin,Vophaverdin,Wofaverdin,Cardio Green,Green, Indocyanine
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D006932 Hyperbilirubinemia A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine. Bilirubinemia,Bilirubinemias,Hyperbilirubinemias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
January 1992, The Journal of biological chemistry,
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
July 1996, Hepatology (Baltimore, Md.),
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
October 1996, Biopharmaceutics & drug disposition,
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
January 1987, Hepatology (Baltimore, Md.),
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
March 1999, Pancreas,
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
October 2004, Drug metabolism and pharmacokinetics,
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
January 1995, Antimicrobial agents and chemotherapy,
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
January 2002, Journal of hepato-biliary-pancreatic surgery,
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
March 1997, Digestive diseases and sciences,
K Sathirakul, and H Suzuki, and K Yasuda, and M Hanano, and O Tagaya, and T Horie, and Y Sugiyama
February 1993, Journal of hepatology,
Copied contents to your clipboard!